AES Corp.
Alice F. Emerson, director, sold 17,348 shares at $16.98 each on April 7 and now holds 17,236.
Bassett Furniture Industries Inc.
Charles T. King, officer, sold 450 shares at $20 each on April 8 and now holds 10.
Eagle Bancorp Inc.
Dudley C. Dworken, director, bought 157 shares at $20.13 each on April 7 and now holds 26,788.
EntreMed Inc.
James S. Burns, chief executive, bought 15,000 shares between $2.35 and $2.40 each on April 6 and now holds 65,000.
Guilford Pharmaceuticals Inc.
Elizabeth M. Greetham, director, bought 10,000 shares at $2.14 each on April 11 and now holds 10,000.
Dean J. Mitchell, chief executive, bought 54,250 shares at $2.17 each on April 8 and now holds 104,250.
Solomon H. Snyder, director, bought 90,000 shares between $2.15 and $2.20 each on April 7 and now holds 90,000.
Willam F. Spengler, chief financial officer, bought 11,375 shares at $2.18 each on April 8 and now holds 18,075.
David C. Uprichard, director, bought 2,000 shares at $2.24 each on April 7 and now holds 2,000.
I.C. Isaacs & Co.
Peter J. Rizzo, chief executive, sold 5,000 shares at $8 each on April 6. [The company indicated that Rizzo now holds 151,667 shares and has options on 500,000 shares.]
Jos. A. Bank Clothiers Inc.
Robert Neal Black, officer, sold 36,000 shares between $30.77 and $34.50 each from April 4 to April 6 and now holds 32,937.
Martek Biosciences Corp.
Eugene H. Rotberg, director, sold 15,000 shares at $60.82 each on April 6 and now holds 41,750.
SI International Inc.
Ray J. Oleson, chief executive, sold 20,000 shares at $28 each from April 6 to April 7 and now holds 210,980.
Spherix Inc.
Lionel Vernon Baldwin, director, bought 3,000 shares between $2.95 and $3 each on April 8 and now holds 23,138.
T. Rowe Price Group Inc.
James Sellers Riepe, officer and director, sold 100,000 shares at $59.22 each on April 6 and now holds 2,028,170.
Trex Co.
Anthony J. Cavanna, director, sold 3,000 shares between $44.02 and $44.48 each on April 7 and now holds 1,351,700.
Andrew U. Ferrari, director, sold 2,500 shares between $44.04 and $44.46 each on April 7 and now holds 660,577.
United Therapeutics Corp.
Frederick T. Hadeed, chief financial officer, sold 2,569 shares at $45.06 each on April 7 and now holds 1,000.
Roger Jeffs, president, sold 3,500 shares at $45.06 each on April 7 and now holds 13,332.
Paul A. Mahon, general counsel, sold 2,000 shares at $45.06 each on April 7 and now holds 12,000.
-- Thomson Financial
